Eva Live Inc. has introduced EvaFarmSight, an AI-powered precision agriculture platform that integrates drone operations, crop monitoring, and AI analytics to help farmers optimize crop health and resource use. This platform leverages the company's autonomous drone technology to provide detailed aerial imagery analysis, targeted treatment plans, and efficient field management. With the global precision farming market expected to nearly double by 2033, Eva aims to capitalize on this growth by offering scalable, subscription-based software solutions that enhance farming efficiency and sustainability. EvaFarmSight represents a strategic expansion from defense technology into agriculture, promising recurring revenue through enterprise licensing and service partnerships.
Eva Live's launch of EvaFarmSight for precision agriculture offers context for readers tracking technology stocks. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: out of 150 priced US tech stocks, 21 rose and 127 fell. Notable movers include FTNT (Fortinet Inc) at USD 126.01 with a 1-day change of -27.61% and 100% buy order activity, NOW (ServiceNow Inc) at USD 122.80 down 18.20% with 93% sell orders, and MRVL (Marvell Technology Inc) at USD 221.88 down 11.83% with a near-even sell/buy split.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
